Evaluating the Effect of a Supplement on Symptoms of Hormonal Imbalance.

A Single-Group Clinical Trial to Evaluate the Effect of an Oral Supplement to Provide Relief From Symptoms of Hormonal Imbalance.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06535698

Enrollment

Registered

2024-08-02

Start date

2024-02-19

Completion date

2024-06-10

Last updated

2024-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women's Health

Keywords

Hormonal Balance Support, Menstrual Cycle, Mood Swings

Brief summary

This is a virtual single-group trial lasting 12 weeks to evaluate the effects of Perelel Health's hormonal balance support on symptoms of hormonal imbalance and overall menstrual health.

Interventions

DIETARY_SUPPLEMENTPerelel Health Hormonal Balance Support

The supplement contains Myo-inositol (1000 mcg), Metabolic balance blend (200 mcg) including Berberine HCl, Alpha lipoic acid, DIM (33'-Diindolylmethane), and D-chiro-inositol (25 mg). Other ingredients include Vegetable cellulose (capsule), plant cellulose, and L-leucine.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Self-reported symptoms of hormonal imbalance (e.g., mood swings, irregular menstrual cycles) * Generally healthy without uncontrolled chronic diseases * Willing to avoid new hormonal balance treatments during the study * Consistent use of current hormonal balance treatments for at least 3 months prior to the study

Exclusion criteria

* Chronic conditions preventing adherence to the protocol Diabetes * Planned hormonal balance-related procedures during the study * Started any new medications or supplements that target hormonal balance in the past 3 months * Anyone with diabetes * Severe allergies requiring EpiPen * Pregnant, breastfeeding, or trying to conceive * Recent surgeries or planned surgeries during the study * Unwilling to follow the study protocol

Design outcomes

Primary

Measure	Time frame	Description
Changes in Symptoms of Hormonal Imbalance	Baseline, Week 4, Week 8, Week 12	Evaluation of the effect of Perelel Health hormonal balance support on symptoms of hormonal imbalance using a self-reported questionnaire.

Secondary

Measure	Time frame	Description
Changes in Overall Menstrual Health	Baseline, Week 4, Week 8, Week 12	Assessment of the impact of Perelel Health hormonal balance support on menstrual health using a self-reported questionnaire.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026